The T-body approach: potential for cancer immunotherapy.
Eshhar
Z
Z
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Bach
N
N
Fitzer-Attas
C J
CJ
Gross
G
G
Lustgarten
J
J
Waks
T
T
Schindler
D G
DG
D000818:Animals; D000917:Antibody Formation / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D016219:Immunotherapy, Adoptive / Q000379:methods*; D013601:T-Lymphocytes / Q000276:immunology*